Renal involvement in HCV-related vasculitis

Fabrizi, 2013, Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease, Am J Kidney Dis, 61, 623, 10.1053/j.ajkd.2012.08.040 Brouet, 1974, Biologic and clinical significance of cryoglobulins. A report of 86 cases, Am J Med, 57, 775, 10.1016/0002-9343(74)90852-3 Cacoub, 1999, Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C, Arthritis Rheum, 42, 2204, 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D Trejo, 2001, Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center, Medicine (Baltimore), 80, 252, 10.1097/00005792-200107000-00004 Saadoun, 2006, Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia, Arch Intern Med, 166, 2101, 10.1001/archinte.166.19.2101 Ferri, 2002, Cryoglobulins, J Clin Pathol, 55, 4, 10.1136/jcp.55.1.4 Meltzer, 1966, Cryoglobulinemia – a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity, Am J Med, 40, 837, 10.1016/0002-9343(66)90200-2 Gorevic, 1980, Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients, Am J Med, 69, 287, 10.1016/0002-9343(80)90390-3 Invernizzi, 1983, Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up, Acta Haematol, 70, 73, 10.1159/000206699 Monti, 1995, Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease, QJM, 88, 115 Terrier, 2013, Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey, Ann Rheum Dis, 72, 374, 10.1136/annrheumdis-2012-201405 Terrier, 2013, The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases, Medicine (Baltimore), 9, 61, 10.1097/MD.0b013e318288925c Terrier, 2012, Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey, Blood, 119, 5996, 10.1182/blood-2011-12-396028 Terrier, 2011, Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis, Arthritis Rheum, 63, 1748, 10.1002/art.30319 Ferri, 2008, Mixed cryoglobulinemia, Orphanet J Rare Dis, 3, 25, 10.1186/1750-1172-3-25 D’Amico, 1998, Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis, Kidney Int, 54, 650, 10.1046/j.1523-1755.1998.00028.x Beddhu, 2002, The clinical and morphologic spectrum of renal cryoglobulinemia, Medicine (Baltimore), 81, 398, 10.1097/00005792-200209000-00005 Tarantino, 1995, Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis, Kidney Int, 47, 618, 10.1038/ki.1995.78 Bonetti, 1997, T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy, J Neuroimmunol, 73, 145, 10.1016/S0165-5728(96)00191-9 Trendelenburg, 2005, The role of complement in cryoglobulin-induced immune complex glomerulonephritis, J Immunol, 175, 6909, 10.4049/jimmunol.175.10.6909 Roccatello, 1993, Role of monocytes in cryoglobulinemia-associated nephritis, Kidney Int, 43, 1150, 10.1038/ki.1993.161 Reininger, 1990, Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms, Proc Natl Acad Sci U S A, 87, 10038, 10.1073/pnas.87.24.10038 Cacoub, 2001, Systemic vasculitis in patients with hepatitis C, J Rheumatol, 28, 109 Saadoun, 2005, Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy, Arthritis Rheum, 52, 2917, 10.1002/art.21270 Agnello, 1992, A role for hepatitis C virus infection in type II cryoglobulinemia, N Engl J Med, 327, 1490, 10.1056/NEJM199211193272104 Hermine, 2002, Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection, N Engl J Med, 347, 89, 10.1056/NEJMoa013376 Saadoun, 2005, Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity, Blood, 105, 74, 10.1182/blood-2004-05-1711 Franzin, 1995, Clonal B-cell expansions in peripheral blood of HCV-infected patients, Br J Haematol, 90, 548, 10.1111/j.1365-2141.1995.tb05582.x Sansonno, 1998, Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia, J Immunol, 160, 3594, 10.4049/jimmunol.160.7.3594 Racanelli, 2001, Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients, J Immunol, 167, 21, 10.4049/jimmunol.167.1.21 Vallat, 2004, Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection, Arthritis Rheum, 50, 3668, 10.1002/art.20594 Ivanovski, 1998, Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas, Blood, 91, 2433, 10.1182/blood.V91.7.2433 De Re, 2000, Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia, Blood, 96, 3578, 10.1182/blood.V96.10.3578 Chan, 2001, V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen, Blood, 97, 1023, 10.1182/blood.V97.4.1023 Rosa, 2005, Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders, Proc Natl Acad Sci U S A, 102, 18544, 10.1073/pnas.0509402102 Zignego, 2000, T(14;18) translocation in chronic hepatitis C virus infection, Hepatology, 31, 474, 10.1002/hep.510310230 Sasso, 2004, Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18), J Immunol, 173, 3549, 10.4049/jimmunol.173.5.3549 Charles, 2008, Clonal expansion of immunoglobulin M+ CD27+ B cells in HCV-associated mixed cryoglobulinemia, Blood, 111, 1344, 10.1182/blood-2007-07-101717 Charles, 2011, Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset, Blood, 117, 5425, 10.1182/blood-2010-10-312942 Terrier, 2011, Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity, J Immunol, 187, 6550, 10.4049/jimmunol.1102022 Ferri, 2004, Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients, Semin Arthritis Rheum, 33, 355, 10.1016/j.semarthrit.2003.10.001 Della Rossa, 2010, Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus, Scand J Rheumatol, 3, 167, 10.3109/03009740903313639 Guillevin, 1996, Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients, Medicine (Baltimore), 75, 17, 10.1097/00005792-199601000-00003 Bonomo, 1987, Treatment of idiopathic mixed cryoglobulinemia with alpha interferon, Am J Med, 83, 726, 10.1016/0002-9343(87)90904-1 Cacoub, 2002, Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis, Arthritis Rheum, 46, 3317, 10.1002/art.10699 Saadoun, 2006, Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: a long-term followup study, Arthritis Rheum, 54, 3696, 10.1002/art.22168 Casato, 1997, Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection, Blood, 90, 3865, 10.1182/blood.V90.10.3865 Misiani, 1994, Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus, N Engl J Med, 330, 751, 10.1056/NEJM199403173301104 Dammacco, 1994, Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study, Blood, 84, 3336, 10.1182/blood.V84.10.3336.3336 Zaja, 2003, Efficacy and safety of rituximab in type II mixed cryoglobulinemia, Blood, 101, 3827, 10.1182/blood-2002-09-2856 Sansonno, 2003, Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20, Blood, 101, 3818, 10.1182/blood-2002-10-3162 Roccatello, 2004, Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis, Nephrol Dial Transplant, 19, 3054, 10.1093/ndt/gfh469 Saadoun, 2008, Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis, Ann Rheum Dis, 67, 1431, 10.1136/ard.2007.081653 Terrier, 2009, Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients, Arthritis Rheum, 60, 2531, 10.1002/art.24703 Saadoun, 2010, Rituximab plus Peg-interferon-{alpha}/ribavirin compared with Peg-interferon-{alpha}/ribavirin in hepatitis C-related mixed cryoglobulinemia, Blood, 116, 326, 10.1182/blood-2009-10-248518 Dammacco, 2010, Pegylated interferon-{alpha}, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study, Blood, 116, 343, 10.1182/blood-2009-10-245878